JP2025084977A5 - - Google Patents

Info

Publication number
JP2025084977A5
JP2025084977A5 JP2025034493A JP2025034493A JP2025084977A5 JP 2025084977 A5 JP2025084977 A5 JP 2025084977A5 JP 2025034493 A JP2025034493 A JP 2025034493A JP 2025034493 A JP2025034493 A JP 2025034493A JP 2025084977 A5 JP2025084977 A5 JP 2025084977A5
Authority
JP
Japan
Prior art keywords
initiation
treatment
monthly
administrations
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025034493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025084977A (ja
JP7852108B2 (ja
Filing date
Publication date
Priority claimed from JP2022000341A external-priority patent/JP7273204B2/ja
Application filed filed Critical
Publication of JP2025084977A publication Critical patent/JP2025084977A/ja
Publication of JP2025084977A5 publication Critical patent/JP2025084977A5/ja
Application granted granted Critical
Publication of JP7852108B2 publication Critical patent/JP7852108B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2025034493A 2018-02-06 2025-03-05 眼科疾患の処置 Active JP7852108B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862627103P 2018-02-06 2018-02-06
US62/627,103 2018-02-06
US201862729333P 2018-09-10 2018-09-10
US62/729,333 2018-09-10
JP2022000341A JP7273204B2 (ja) 2018-02-06 2022-01-05 眼科疾患の処置
JP2023073187A JP7646727B2 (ja) 2018-02-06 2023-04-27 眼科疾患の処置

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023073187A Division JP7646727B2 (ja) 2018-02-06 2023-04-27 眼科疾患の処置

Publications (3)

Publication Number Publication Date
JP2025084977A JP2025084977A (ja) 2025-06-03
JP2025084977A5 true JP2025084977A5 (https=) 2026-03-06
JP7852108B2 JP7852108B2 (ja) 2026-04-27

Family

ID=

Similar Documents

Publication Publication Date Title
JP2023099094A5 (https=)
US20100047204A1 (en) Use of organic compounds
US20220002402A1 (en) Methods of treating graves' ophthalmopathy using anti-fcrn antibodies
CN114558129A (zh) 用于降低心血管风险的方法
IL276383B2 (en) Treatment of ophthalmologic diseases
CN111787981B (zh) 增加肌肉量和减少脂肪量的方法
JP2022506111A5 (https=)
JP2019521156A5 (https=)
TW202310872A (zh) 藉由投予ｐｃｓｋ９抑制劑治療糖尿病患者高血脂症之方法
JP2025530139A (ja) 抗ＦｃＲＮ抗体を用いた慢性炎症性脱髄性多発神経障害の治療方法
JP2020535161A5 (https=)
JP2022062153A (ja) デュラグルチドを使用する方法およびデュラグルチドを含有する組成物
JP7722991B2 (ja) 抗ｆｃｒｎ抗体を用いた温熱自己免疫性溶血性貧血の治療方法
JP2021523881A5 (https=)
JPWO2020092019A5 (https=)
JP2025084977A5 (https=)
AU2018303836B2 (en) Treatment of CD20-positive B-cell lymphoma with obituzumab
JP2025084976A5 (https=)
TW201636042A (zh) 使用持續釋放ｅｐｏ之製劑治療貧血之方法
JPWO2022245739A5 (https=)
WO2021018191A1 (zh) Il-17拮抗剂治疗自身免疫疾病的方法
JPWO2021228987A5 (https=)
JPWO2019186369A5 (https=)
WO2018096467A1 (en) Methods of treating acne using interleukin-17 (il-17) antagonists
CN115812079A (zh) 使用白细胞介素-17(il-17)拮抗剂治疗甲状腺眼病和格雷夫斯眼眶病的方法